Barinthus Biotherapeutics PLBRNS
13F holders, Q1 2024 (March 31)15holders
1famous investor
$2.20avg. 13F price*
At the end of Q1 2024, 15 institutions reported holding Barinthus Biotherapeutics PL (BRNS) in their 13F filings. The largest holders were M&G PLC ($10.4M), HSG Holding Ltd ($3.6M) and Alphabet Inc. ($3.6M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Barinthus Biotherapeutics PL
- CUSIP
- 91864C107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 15 holders
| M&G PLC | 0.07% | — | 5,197,349 | $10.4M |
| HSG Holding Ltd | 0.34% | No change | 1,420,473 | $3.6M |
| Alphabet Inc. | 0.14% | No change | 1,513,644 | $3.6M |
| DC Funds, LP | 14.77% | No change | 642,204 | $1.5M |
| BlueCrest Capital Management Ltd | 0.65% | No change | 542,673 | $1.3M |
| Baird Financial Group, Inc. | 0.00% | Reduce -14.6% | 167,705 | $399K |
| Johns Hopkins University | 0.01% | Add +13.2% | 122,237 | $291K |
| Renaissance Technologies | 0.00% | Reduce -6.7% | 27,700 | $66K |
| Ipswich Investment Management Co., Inc. | 0.01% | No change | 23,075 | $55K |
| Janney Montgomery Scott LLC | 0.00% | No change | 15,008 | $36K |
| Morgan Stanley | 0.00% | Reduce -21.9% | 12,862 | $31K |
| Geode Capital Management, LLC | 0.00% | No change | 11,568 | $28K |
| UBS Group AG | 0.00% | No change | 1,547 | $4K |
| New England Capital Financial Advisors LLC | 0.00% | No change | 104 | $248 |
| Rhumbline Advisers | 0.00% | No change | 60 | $144 |
"% of holder's portfolio" is BRNS's weight in each manager's 13F, not the share of Barinthus Biotherapeutics PL the manager owns.